Innovator IBD 50 ETF (FFTY) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.00: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerInnovator IBD 50 ETF (FFTY) trades at $35.39. Innovator IBD 50 ETF (FFTY) aims to replicate the performance of the IBD® 50 Index, which comprises the top 50 growth stocks identified by Investor's Business Daily®.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for FFTY: FFTY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Innovator IBD 50 ETF Company Overview
Innovator IBD 50 ETF (FFTY) seeks to mirror the IBD® 50 Index, a rules-based index of 50 top growth stocks selected by Investor's Business Daily. FFTY offers investors exposure to a concentrated portfolio of companies exhibiting strong growth characteristics, within the broader market landscape.
What Is the Investment Thesis for FFTY?
The investment thesis for Innovator IBD 50 ETF (FFTY) centers on its ability to capture the performance of high-growth stocks identified by the IBD® 50 Index. Key value drivers include the index's rules-based methodology, which aims to select companies with strong earnings and price momentum. A potential catalyst is the continued outperformance of growth stocks relative to value stocks. Risk factors include the concentrated nature of the portfolio (50 stocks) and the potential for the IBD® 50 Index methodology to underperform in certain market environments. The ETF's performance is directly tied to the effectiveness of the IBD® 50 Index in identifying and selecting high-growth companies.
Based on FMP financials and quantitative analysis
FFTY Key Highlights
FFTY invests at least 80% of its net assets in securities comprising the IBD® 50 Index, providing focused exposure.
- The IBD® 50 Index is a rules-based index compiled by Investor's Business Daily, targeting top growth stocks.
- FFTY offers a concentrated portfolio of 50 stocks, potentially leading to higher volatility.
- The ETF's performance is directly linked to the effectiveness of the IBD® 50 Index methodology.
- FFTY has a beta of 1.00, indicating market-average volatility.
Who Are FFTY's Competitors?
FFTY is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| IWF iShares Russell 1000 Growth ETF | $128.35 | +1.01% | $140B | — |
| VUG Vanguard Growth ETF | $92.06 | +0.98% | $406B | — |
| QQQ Invesco QQQ Trust, Series 1 | $756.20 | +0.88% | $539B | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FFTY's Key Strengths?
Rules-based methodology for stock selection.
- Exposure to a concentrated portfolio of growth stocks.
- Brand recognition of the IBD® 50 Index.
- Transparent and liquid investment vehicle.
What Are FFTY's Weaknesses?
Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Higher expense ratio compared to some broad-based growth ETFs.
What Are the Key Risks for FFTY?
Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Competition from other growth ETFs.
- Changes in market conditions that favor value stocks.
What Are FFTY's Competitive Advantages?
- Brand Recognition: The IBD® 50 Index has brand recognition through Investor's Business Daily.
- Rules-Based Methodology: The index uses a systematic approach to stock selection.
- First-Mover Advantage: FFTY was one of the first ETFs to track the IBD® 50 Index.
What Does FFTY Do?
Innovator IBD 50 ETF (FFTY) is designed to track the performance of the IBD® 50 Index. The fund was created to provide investors with a focused approach to investing in growth stocks. The IBD® 50 Index is a rules-based, computer-generated stock index compiled and published weekly by Investor's Business Daily® (IBD). This index aims to identify the top 50 growth stocks based on specific fundamental and technical criteria. FFTY invests at least 80% of its net assets, including investment borrowings, in the securities that make up the index. The ETF offers a way for investors to gain exposure to a dynamic selection of growth-oriented companies identified by IBD's proprietary methodology. The composition of the index is reviewed and rebalanced regularly, reflecting changes in market conditions and company performance, ensuring the ETF remains focused on high-growth potential stocks. FFTY provides a single investment vehicle to access a diversified portfolio of growth stocks selected using a systematic approach.
What Products and Services Does FFTY Offer?
- Tracks the performance of the IBD® 50 Index.
- Invests primarily in equity securities of companies included in the index.
- Utilizes a rules-based methodology for stock selection.
- Provides exposure to a concentrated portfolio of 50 growth stocks.
- Rebalances its portfolio regularly to reflect changes in the index.
- Offers investors a way to access a diversified basket of growth-oriented companies.
How Does FFTY Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- AUM growth is driven by investment performance and investor inflows.
- The fund's profitability is dependent on its ability to attract and retain assets.
What Industry Does FFTY Operate In?
Innovator IBD 50 ETF (FFTY) operates within the broader exchange-traded fund (ETF) market, specifically targeting growth stock investments. The ETF market has experienced significant growth in recent years, driven by increasing investor demand for diversified, low-cost investment vehicles. FFTY competes with other growth-focused ETFs, but differentiates itself through its reliance on the IBD® 50 Index, which uses a rules-based methodology to select high-growth companies. The competitive landscape includes both broad-based growth ETFs and those focused on specific sectors or investment themes.
Who Are FFTY's Key Customers?
- Retail investors seeking exposure to growth stocks.
- Financial advisors looking for diversified investment solutions.
- Institutional investors seeking to implement growth-oriented strategies.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
| 2026-10-05 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -2.4%.
FFTY Financials
Bull Case vs Bear Case
Bull Case
- Rules-based methodology for stock selection.
- Exposure to a concentrated portfolio of growth stocks.
- Brand recognition of the IBD® 50 Index.
- Transparent and liquid investment vehicle.
Bear Case
- Concentrated portfolio may lead to higher volatility.
- Performance is dependent on the effectiveness of the IBD® 50 Index methodology.
- May underperform in certain market environments.
- Higher expense ratio compared to some broad-based growth ETFs.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
FFTY Latest News
No recent news available for FFTY.
FFTY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FFTY.
Price Targets
Wall Street price target analysis for FFTY.
FFTY MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FFTY; grades run from A+ (80-100) to F (below 30).
Innovator IBD 50 ETF Stock: Key Questions Answered
What are the main risks for FFTY?
The main risks for FFTY include the concentrated nature of its portfolio, which can lead to higher volatility compared to more diversified ETFs.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The IBD® 50 Index methodology is proprietary and may not be fully transparent.